Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 6, 2013, Pages 805-812

  Shuster, Anatoly ^a   Huynh, Thien J ^a   Rajan, Dheeraj K ^a   Marquez, Max A ^a   Grant, David R ^a   Huynh, Dan C ^a   Jaskolka, Jeffrey D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETHIODIZED OIL; IODINATED POPPYSEED OIL;

ADULT; AGED; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT RESPONSE;

EID: 84878114576     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.01.499     Document Type: Article

References (36)

1. W.P. Zhou, E.C. Lai, and A.J. Li A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma Ann Surg 249 2009 195 202
2. F.X. Bosch, J. Ribes, M. Díaz, and R. Cléries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 2004 5 16
3. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
4. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
5. M.A. Zimmerman, R.M. Ghobrial, and M.J. Tong Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators Arch Surg 143 2008 182 188
6. I.W. Graziadei, H. Sandmueller, and P. Waldenberger Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 2003 557 563
7. Y.K. Maddala, L. Stadheim, and J.C. Andrews Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization Liver Transpl 10 2004 449 455
8. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
9. F.Y. Yao, N.M. Bass, and B. Nikolai Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873 883
10. Z. Haider, T. ul Haq, K. Munir, M.U. Usman, and M. Azeemuddin Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma J Coll Physicians Surg Pak 16 2006 265 269
11. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 15 2002 1164 1171
12. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
13. C. Camma, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
14. P.E. Majno, R. Adam, and H. Bismuth Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
15. D. Seehofer, M. Nebrig, and T. Denecke Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis Clin Transplant 26 2012 764 774
16. I. Bargellini, C. Vignali, and R. Cioni Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria - selection parameter for liver transplantation Radiology 25 2010 289 300
17. G. Otto, M. Heise, and C. Moench Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma Transplant Proc 39 2007 537 539
18. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267
19. A. Bouchard-Fortier, R. Lapointe, P. Perreault, L. Bouchard, and G. Pomier-Layrargues Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation: a retrospective study Int J Hepatol 2011 2011 974514
20. E. Alba, C. Valls, and J. Dominguez Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation AJR Am J Roentgenol 190 2008 1341 1348
21. M. Lesurtel, B. Müllhaupt, B.C. Pestalozzi, T. Pfammatter, and P.A. Clavien Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2006 2644 2650
22. T. Decaens, F. Roudot-Thoraval, and S. Bresson-Hadni Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 2005 767 775
23. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
24. J. Bruix, M. Sherman, and J.M. Llovet EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
25. A. Riaz, K. Memon, and F.H. Miller Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation J Hepatol 54 2011 695 704
26. R.J. Lewandowski, M.F. Mulcahy, and L.M. Kulik Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort Radiology 255 2010 955 965
27. J.B. Sørensen, M. Klee, T. Palshof, and H.H. Hansen Performance status assessment in cancer patients: an inter-observer variability study Br J Cancer 67 1993 773 775
28. D. DuBay, C. Sandroussi, and L. Sandhu Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion Ann Surg 253 2011 166 172
29. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 147 1981 207 214
30. K.J. Oldhafer, A. Chavan, and N.R. Frühauf Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 29 1998 953 959
31. S. Roayaie, J.S. Frischer, and S.H. Emre Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539
32. B. Pérez Saborido, J.C. Meneu, E. Moreno, I. García, A. Moreno, and Y. Fundora Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 190 2005 383 387
33. A. Veltri, M. Grosso, and M.C. Martina Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study Cardiovasc Intervent Radiol 21 1998 393 398
34. R. Salem, R.J. Lewandowski, and B. Atassi Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 2005 1627 1639
35. J.H. Shim, H.C. Lee, and S.O. Kim Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 2012 708 718
36. R. Gillmore, S. Stuart, and A. Kirkwood EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation J Hepatol 55 2011 1309 1316